There is still no clear cut therapy for 17p. My wife was in a clinical trial with Ibrutinib for 3.5 years at NIH. When she relapsed it was off to Stanford for the much hyped Venetoclax. That lasted about 8 months. NEXT up was CAR-T in Seattle. We had to live there for three months. Thirty days after in fusion she was declared CLL free. At here 90 day check up CLL was back. We will be returning to Seattle for a TGR-1202 trial. Any thoughts?
You must log in to use this feature, please click here to login.